{"id":4060,"date":"2026-02-02T19:19:52","date_gmt":"2026-02-03T00:19:52","guid":{"rendered":"https:\/\/ghazani-lab.bwh.harvard.edu\/?page_id=4060"},"modified":"2026-02-02T19:26:36","modified_gmt":"2026-02-03T00:26:36","slug":"genome-portals","status":"publish","type":"page","link":"https:\/\/ghazani-lab.bwh.harvard.edu\/index.php\/genome-portals\/","title":{"rendered":"GENOME PORTALS"},"content":{"rendered":"
\n \n
\n \n \n
\n \n
\n \n
\n \n
\n
\n \n \n
\n \n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n \n \n
\n \n
\n \n
\n \n
\n
\n \n \n
\n \n
\n \n
\n \n \n

GENOME PORTALS<\/h1>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n \n \n
\n \n
\n \n
\n \n
\n
\n \n \n
\n \n
\n \n
\n
\n \n \n \n
<\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n \n
\n \n
\n
\n \n \n
\n \n
\n \n
\n \n \n

INT\u00b2GRATE Portal<\/h3>\n <\/div>\n <\/div>\n
\n \n \n
\n

Part of the INT\u00b2GRATE Oncology Consortium, the INT\u00b2GRATE Variant Portal provides a comprehensive assessment of variant actionability by integrating tumor and germline data, including detailed clinical evidence and analysis\n of differential and allelic conditions.<\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n \n
Go to INT\u00b2GRATE Portal<\/span> <\/path><\/svg><\/span><\/a>\n <\/span>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n \n \n
\n \n
\n \n
\n
\n \n \n \"\"\n
<\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n \n
\n \n
\n
\n \n \n
\n \n
\n \n
\n \n \n

TCGenome Portal<\/h3>\n <\/div>\n <\/div>\n
\n \n \n
\n

Part of the multi-institutional TCGenome program, the portal presents an aggregate database of genome variants from individuals who underwent universal cancer genetic testing and provides a comprehensive resource to support\n population-focused precision medicine.<\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n \n
Go to TCGenome Portal<\/span> <\/path><\/svg><\/span><\/a>\n <\/span>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"

GENOME PORTALS INT\u00b2GRATE Portal Part of the INT\u00b2GRATE Oncology Consortium, the INT\u00b2GRATE Variant Portal provides a comprehensive assessment of variant actionability by integrating tumor and germline data, including detailed clinical evidence and analysis of differential and allelic conditions. Go to INT\u00b2GRATE Portal TCGenome Portal Part of the multi-institutional TCGenome program, the portal presents an aggregate […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-templates\/full-width-page.php","meta":{"_themeisle_gutenberg_block_has_review":false,"footnotes":""},"class_list":["post-4060","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/ghazani-lab.bwh.harvard.edu\/index.php\/wp-json\/wp\/v2\/pages\/4060","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ghazani-lab.bwh.harvard.edu\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ghazani-lab.bwh.harvard.edu\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ghazani-lab.bwh.harvard.edu\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ghazani-lab.bwh.harvard.edu\/index.php\/wp-json\/wp\/v2\/comments?post=4060"}],"version-history":[{"count":4,"href":"https:\/\/ghazani-lab.bwh.harvard.edu\/index.php\/wp-json\/wp\/v2\/pages\/4060\/revisions"}],"predecessor-version":[{"id":4105,"href":"https:\/\/ghazani-lab.bwh.harvard.edu\/index.php\/wp-json\/wp\/v2\/pages\/4060\/revisions\/4105"}],"wp:attachment":[{"href":"https:\/\/ghazani-lab.bwh.harvard.edu\/index.php\/wp-json\/wp\/v2\/media?parent=4060"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}